UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 164

Sortiert nach

A Systematic Review of Conversion From Calcineurin Inhibitor to Mammalian Target of Rapamycin Inhibitors for Maintenance Immunosuppression in Kidney Transplant Recipients

American journal of transplantation, 2014-09, Vol.14 (9), p.2106-2119

2014

Link zum Volltext

Verfügbarkeit prüfen

A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients

British journal of dermatology (1951), 2016-11, Vol.175 (5), p.1073-1075

2016

Link zum Volltext

Verfügbarkeit prüfen

Sotrastaurin in Calcineurin Inhibitor–Free Regimen Using Everolimus in De Novo Kidney Transplant Recipients

American journal of transplantation, 2013-07, Vol.13 (7), p.1757-1768

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Sotrastaurin Plus Tacrolimus After De Novo Kidney Transplantation: Randomized, Phase II Trial Results

American journal of transplantation, 2013-07, Vol.13 (7), p.1746-1756

2013

Link zum Volltext

Verfügbarkeit prüfen

FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1‐Year, Randomized Controlled Trial in Europe and Australasia

American journal of transplantation, 2006-12, Vol.6 (12), p.2912-2921

2006

Link zum Volltext

Verfügbarkeit prüfen

Early up-regulation of macrophages and myofibroblasts: a new marker for development of chronic renal allograft rejection

Transplantation, 2000-06, Vol.69 (12), p.2658

2000

Link zum Volltext

Verfügbarkeit prüfen

Interleukin‐18 Affects Local Cytokine Expression But Does Not Impact on the Development of Kidney Allograft Rejection

American journal of transplantation, 2006-11, Vol.6 (11), p.2612-2621

2006

Link zum Volltext

Verfügbarkeit prüfen

Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I

Immunology and cell biology, 2001-06, Vol.79 (3), p.213-221

2001

Link zum Volltext

Verfügbarkeit prüfen

Macrophage-derived interleukin-18 in experimental renal allograft rejection

Nephrology, dialysis, transplantation, 2005-04, Vol.20 (4), p.699-706

2005

Link zum Volltext

Verfügbarkeit prüfen

Vascular endothelial growth factor expression in human chronic renal allograft rejection

Transplantation, 1999-03, Vol.67 (6), p.929

1999

Link zum Volltext

Verfügbarkeit prüfen

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial

Transplantation, 2009-01, Vol.87 (2), p.233

2009

Link zum Volltext

Verfügbarkeit prüfen

Anergic Self-Reactive B Cells Present Self Antigen and Respond Normally to CD40-Dependent T-Cell Signals but are Defective in Antigen-Receptor- Mediated Functions

Proceedings of the National Academy of Sciences - PNAS, 1994-05, Vol.91 (10), p.4392-4396

1994

Link zum Volltext

Verfügbarkeit prüfen

Drug points: Premature osteonecrosis and sirolimus treatment in renal transplantation

BMJ (Online), 2001-09, Vol.323 (7314), p.665

2001

Link zum Volltext

Verfügbarkeit prüfen

Graft Function, Cardiovascular Risk Factors, and Sex Hormones in Renal Transplant Recipients on an Immunosuppressive Regimen of Everolimus, Reduced Dose of Cyclosporine, and Basiliximab

Transplantation proceedings, 2005-04, Vol.37 (3), p.1601-1604

2005

Link zum Volltext

Verfügbarkeit prüfen

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

Transplantation, 2001-09, Vol.72 (5), p.777

2001

Link zum Volltext

Verfügbarkeit prüfen

Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance

European journal of clinical pharmacology, 2000-08, Vol.56 (5), p.395-398

2000

Link zum Volltext

Verfügbarkeit prüfen

Tacrolimus Once Daily (ADVAGRAF) Versus Twice Daily (PROGRAF) in De Novo Renal Transplantation: A Randomized Phase III Study

American journal of transplantation, 2010-12, Vol.10 (12), p.2632-2643

2010

Link zum Volltext

Verfügbarkeit prüfen

Sirolimus-Based Therapy With or Without Cyclosporine: Long-Term Follow-up in Renal Transplant Patients

Transplantation proceedings, 2005-03, Vol.37 (2), p.693-696

2005

Link zum Volltext

Verfügbarkeit prüfen

Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients

Transplantation proceedings, 2003-05, Vol.35 (3), p.S115-S117

2003

Link zum Volltext

Verfügbarkeit prüfen

Sirolimus reduces vasculopathy but exacerbates proteinuria in association with inhibition of VEGF and VEGFR in a rat kidney model of chronic allograft dysfunction

Nephrology, dialysis, transplantation, 2013-02, Vol.28 (2), p.327-336

2013

Link zum Volltext

Verfügbarkeit prüfen

Increased Risk of Hemorrhagic Complications in Renal Allograft Recipients Receiving Systemic Heparin Early Posttransplantation

Transplantation proceedings, 2005-03, Vol.37 (2), p.1026-1028

2005

Link zum Volltext

Verfügbarkeit prüfen

Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6‐Month Safety and Efficacy Results of Two Randomized Studies

American journal of transplantation, 2004-04, Vol.4 (4), p.626-635

2004

Link zum Volltext

Verfügbarkeit prüfen

Frequency of cytochrome P 450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance

European journal of clinical pharmacology, 2000-08, Vol.56 (5), p.395-398

2000

Link zum Volltext

Verfügbarkeit prüfen

Cyclosporine withdrawal improves long-term graft survival in renal transplantation

Transplantation, 2009-06, Vol.87 (12), p.1877

2009

Link zum Volltext

Verfügbarkeit prüfen

Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement

Medical journal of Australia, 2005-08, Vol.183 (3), p.138-141

Mathew, Timothy H

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(139)

Publikationsform

Sprache

Englisch
(161)
Japanisch
(20)
Deutsch
(2)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(114)
Life Sciences & Biomedicine
(89)
Humans
(64)
Male
(46)
Female
(41)
Transplantation
(38)
Adult
(37)
Biological And Medical Sciences
(36)
Medical Sciences
(35)
Middle Aged
(34)
Surgery
(29)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(24)
Technology
(24)
Computer Science
(22)
Immunology
(21)
Kidney Transplantation
(19)
Aged
(18)
Computer Science, Artificial Intelligence
(17)
Kidney Transplantation - Immunology
(16)
Surgery Of The Urinary System
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A Systematic Review of Conversion From Calcineurin Inhibitor to Mammalian Target of Rapamycin Inhibitors for Maintenance Immunosuppression in Kidney Transplant Recipients

A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients

Sotrastaurin in Calcineurin Inhibitor–Free Regimen Using Everolimus in De Novo Kidney Transplant Recipients

Efficacy of Sotrastaurin Plus Tacrolimus After De Novo Kidney Transplantation: Randomized, Phase II Trial Results

FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1‐Year, Randomized Controlled Trial in Europe and Australasia

Early up-regulation of macrophages and myofibroblasts: a new marker for development of chronic renal allograft rejection

Interleukin‐18 Affects Local Cytokine Expression But Does Not Impact on the Development of Kidney Allograft Rejection

Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I

Macrophage-derived interleukin-18 in experimental renal allograft rejection

Vascular endothelial growth factor expression in human chronic renal allograft rejection

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial

Anergic Self-Reactive B Cells Present Self Antigen and Respond Normally to CD40-Dependent T-Cell Signals but are Defective in Antigen-Receptor- Mediated Functions

Drug points: Premature osteonecrosis and sirolimus treatment in renal transplantation

Graft Function, Cardiovascular Risk Factors, and Sex Hormones in Renal Transplant Recipients on an Immunosuppressive Regimen of Everolimus, Reduced Dose of Cyclosporine, and Basiliximab

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance

Tacrolimus Once Daily (ADVAGRAF) Versus Twice Daily (PROGRAF) in De Novo Renal Transplantation: A Randomized Phase III Study

Sirolimus-Based Therapy With or Without Cyclosporine: Long-Term Follow-up in Renal Transplant Patients

Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients

Sirolimus reduces vasculopathy but exacerbates proteinuria in association with inhibition of VEGF and VEGFR in a rat kidney model of chronic allograft dysfunction

Increased Risk of Hemorrhagic Complications in Renal Allograft Recipients Receiving Systemic Heparin Early Posttransplantation

Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6‐Month Safety and Efficacy Results of Two Randomized Studies

Frequency of cytochrome P 450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance

Cyclosporine withdrawal improves long-term graft survival in renal transplantation

Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement

Suchergebnisse filtern